152 related articles for article (PubMed ID: 11714895)
1. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.
Marsch LA; Bickel WK; Badger GJ; Rathmell JP; Swedberg MD; Jonzon B; Norsten-Höög C
J Pharmacol Exp Ther; 2001 Dec; 299(3):1056-65. PubMed ID: 11714895
[TBL] [Abstract][Full Text] [Related]
2. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
Zacny JP; Conley K; Marks S
J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
[TBL] [Abstract][Full Text] [Related]
3. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers.
Walker DJ; Zacny JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1454-64. PubMed ID: 10336539
[TBL] [Abstract][Full Text] [Related]
4. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.
Zacny JP; Conley K; Galinkin J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1187-97. PubMed ID: 9316825
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
[TBL] [Abstract][Full Text] [Related]
6. Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.
Zacny JP
Drug Alcohol Depend; 2005 Nov; 80(2):273-8. PubMed ID: 16005162
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
Zacny JP
Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
[TBL] [Abstract][Full Text] [Related]
8. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers.
Zacny JP; Hill JL; Black ML; Sadeghi P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1197-207. PubMed ID: 9732379
[TBL] [Abstract][Full Text] [Related]
9. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers.
Zacny JP; Lichtor JL; Flemming D; Coalson DW; Thompson WK
J Pharmacol Exp Ther; 1994 Jan; 268(1):1-9. PubMed ID: 8301543
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
Foltin RW; Fischman MW
J Pharmacol Exp Ther; 1992 May; 261(2):623-32. PubMed ID: 1578376
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
13. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers.
Zacny JP; Lichtor JL; Thapar P; Coalson DW; Flemming D; Thompson WK
J Pharmacol Exp Ther; 1994 Aug; 270(2):579-88. PubMed ID: 8071850
[TBL] [Abstract][Full Text] [Related]
14. Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [35S]GTPgammaS binding.
Kruzich PJ; Chen AC; Unterwald EM; Kreek MJ
Synapse; 2003 Mar; 47(4):243-9. PubMed ID: 12539196
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the abuse potential of methocarbamol.
Preston KL; Guarino JJ; Kirk WT; Griffiths RR
J Pharmacol Exp Ther; 1989 Mar; 248(3):1146-57. PubMed ID: 2703967
[TBL] [Abstract][Full Text] [Related]
17. The reinforcing and subjective effects of morphine in post-addicts: a dose-response study.
Lamb RJ; Preston KL; Schindler CW; Meisch RA; Davis F; Katz JL; Henningfield JE; Goldberg SR
J Pharmacol Exp Ther; 1991 Dec; 259(3):1165-73. PubMed ID: 1762068
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Psychopharmacology (Berl); 2003 Nov; 170(3):242-254. PubMed ID: 12955305
[TBL] [Abstract][Full Text] [Related]
19. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
Zacny JP; Gutierrez S; Bolbolan SA
Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
[TBL] [Abstract][Full Text] [Related]
20. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
